Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Jan 30, 2023
One-size-fits-all COVID-19 booster plan needs a rethink
Public health officials should recognize that additional COVID-19 booster shots should now be a more nuanced decision.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
LIFE
Jan 28, 2023
Across China, folk remedies remain a popular, if unproven, COVID cure
A combination of shortages of Western medicines and long-standing traditions has kept these homespun treatments in the spotlight.
Japan Times
JAPAN / Science & Health
Jan 27, 2023
Abortion pill gets OK from Japan government panel in major step toward final approval
Abortion is legal in Japan up to 22 weeks, but a surgical procedure is currently the only option available for women and consent is usually required from a spouse or partner.
Japan Times
JAPAN / Science & Health
Jan 26, 2023
Japan launches electronic prescriptions nationwide
The health ministry said that around 30,000 facilities have already applied to start electronic prescriptions.
Japan Times
WORLD
Jan 26, 2023
Updated COVID-19 vaccines prevented illness from latest variants, CDC says
The analysis found that the updated vaccine helped prevent illness in people who had previously received two to four doses of the original COVID-19 vaccine.
Japan Times
COMMENTARY / World
Jan 22, 2023
For China, it's the ordinary people who pose the greatest risk
In times of crisis, such as the COVID pandemic, Chinese leaders are so terrified of public panic that they view the people as the actual source of the crisis at hand.
Japan Times
ASIA PACIFIC
Jan 22, 2023
China COVID-19 deaths exceed 12,600 in week before Lunar New Year
There were 12,658 COVID-19-linked deaths at hospitals between Jan. 13 and 19, the Chinese Center for Disease Control and Prevention said in a statement.
Japan Times
WORLD / Science & Health
Jan 19, 2023
COVID immunity lasts at least a year after infection plus shots, study says
The combination prevented more than 97% of severe disease or hospitalization for up to 12 months after infection or initial immunization.
Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer's COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
ASIA PACIFIC
Jan 15, 2023
China’s 60,000 COVID-19 death toll spurs calls for more data
China COVID-19 surge since December has spurred concern about variants; WHO chief stresses importance of transparency.
Japan Times
JAPAN
Jan 13, 2023
Hospital given COVID-19 aid refused to accept patient, Japan auditor says
In response to the board's inquiry, one hospital explained that it had to refuse a patient for a bed because of a shortage of nurses.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
EDITORIALS
Jan 13, 2023
Health concerns, not pride, should guide COVID-19 travel policy
Apparently China can shut its borders to reduce the risk of COVID-19 infections, but Beijing doesn't think other countries should do the same.
Japan Times
COMMENTARY / World
Jan 12, 2023
Why the future of technology is so hard to predict
It's 2023, yet we're not all riding Segways, having sex with robots or cloning humans. What gives?
Japan Times
COMMENTARY / World
Jan 11, 2023
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Japan Times
JAPAN
Jan 11, 2023
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?